The OIS Situation Room: Navigating healthcare in a shifting world order

At this year’s Retina Innovation Summit, industry experts and leaders gathered in a two-part discussion on investment trends, regulatory environment and FDA changes, emerging therapies in ophthalmology, and more. Panelists include: Laura Feinleib, Managing Director at Redmile Group; Derrick Li, Chief Strategy Officer at ODC Life Sciences; Cameron Taylor, Managing Director at BofA Securities | Life Sciences; Wayne Caulder, Vice President & General Manager of Surgical (U.S. & Canada) at Bausch + Lomb; Paul Hallen, Vice President & Distinguished Fellow at Alcon; Nida Sen, MD, VP, Ophthalmology Strategy & Development Head at Sanofi; and Julian Smith, General Manager Portfolio Commercial Strategy - Eye Care at AbbVie. In this panel learn about: 🔹Investment trends in public and private markets 🔹Regenerative therapies, such as gene therapy and cell therapy 🔹The impact of patient and therapy adoption challenges—and how to navigate them 🔹Advice for entrepreneurs and start-ups on the best key strategies on driving partnership interest and networking

Listen